Beta-caryophyllene is a dietary cannabinoid
By J. Gertsch, M. Leonti, Stefan Raduner, I. Rácz, Jian-zhong Chen, X. Xie, K. Altmann, Meliha Karsak, A. Zimmer. Proceedings of the National Academy of Sciences of the United States of America, 2008
852 citations recorded by the source corpus.
Subfields: Clinical Psychology, Cognitive Neuroscience, Pharmacology
View Paper: https://www.semanticscholar.org/paper/3e1829f6b0f1b34733e6c808345d7905073c34c1
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cognitive Neuroscience
Citations in the corpus
- β‐caryophyllene and β‐caryophyllene oxide—natural compounds of anticancer and analgesic properties (2016, background): “In addition, all these compounds did not bind to CB1 [14].”
- Herbal extracts and phytochemicals: plant secondary metabolites and the enhancement of human brain function. (2011, background): “It is notable that b-caryophyllene is also a cannabinoid type 2 receptor ligand and thus offers potential for the prevention and treatment of inflammation (149).”